The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
global cell freezing media market poised for significant growth by 2033
The global cell freezing media market is projected to exceed $387.5 million by 2033, growing at a CAGR of 9.66% from 2023. North America is expected to dominate the market due to advanced healthcare infrastructure, while Asia-Pacific is anticipated to experience the fastest growth, driven by low costs and a focus on biologics manufacturing. Key players include Thermo Fisher Scientific and Merck, with innovations in cryopreservation techniques fueling market expansion.
ubs raises price target for sartorius vz shares to 278 euros
UBS AG has raised its price target for Sartorius vz shares from 264 to 278 euros, maintaining a "Neutral" rating following the third quarter results. Despite a 23.9% decline in share price over 2024, the stock shows a potential upside of 9.92% relative to the new target. The Q4 2024 balance sheet is expected to be presented on January 23, 2025.
Sartorius AG maintains neutral rating amid diverse pharmaceutical equipment offerings
Sartorius AG, a German supplier of pharmaceutical and laboratory equipment, operates in two main sectors: bioprocess solutions and laboratory products and services. The Bioprocess Solutions segment provides integrated solutions for biopharmaceutical manufacturing, including sterilization filters and single-use bags, while the Laboratory Products and Services segment offers instruments and consumables for laboratory use, such as balances and filtration systems.
ubs maintains neutral rating for sartorius with target price of 264 euros
UBS AG maintains a "Neutral" rating for Sartorius vz shares with a target price of 264 euros, following third-quarter results that showed consolidated sales below expectations but an operating result in line with forecasts. The share price rose 13.9% to EUR 260.30, indicating potential for further growth, despite a 21.7% decline since the start of 2024. Sartorius is set to release its Q3 2024 results on October 17, 2024.
ubs maintains neutral rating on sartorius vz shares with target price of 264 euros
UBS AG has maintained a "Neutral" rating on Sartorius vz shares, setting a target price of 264 euros following the third-quarter results. While consolidated sales fell short of expectations, the operating result met forecasts, and a recovery in the BPS division may positively influence the market. Sartorius vz shares rose 13.9% in XETRA trading, though they have declined 21.7% since the start of 2024.
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.